Characterizing Malignant Tumors Using Ultrasound Doppler Imaging

Overview

The aim of this study is to determine whether Ultrasound Doppler imaging can identify malignant tumors at a very early stage.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2019

Interventions

  • Device: Ultrasound
    • Ultrasound imaging of women arriving at clinic for routine care

Arms, Groups and Cohorts

  • Women with malignant tumor
    • Women with malignant tumor in reproductive system
  • Women with benign tumor
    • Women with benign tumor in reproductive system
  • Women with no observed tumor
    • Women with no observed tumor in reproductive system

Clinical Trial Outcome Measures

Primary Measures

  • Early characterization of malignant tumors
    • Time Frame: One year
    • Comparison of Ultrasound Doppler findings at different speeds between women without tumors, with benign tumors and with malignant tumors of reproductive system

Participating in This Clinical Trial

Inclusion Criteria

  • Women presenting for routine abdominal/vaginal ultrasound Exclusion Criteria:

  • Pregnant women

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hillel Yaffe Medical Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Alon Shrim, MD, Principal Investigator, Hillel Yaffe Medical Center
  • Overall Contact(s)
    • Genya Peisahov, BSc, 972-54-8886349, genyap@hymc.gov.il

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.